Efficacy of switching from adefovir to tenofovir in chronic hepatitis B patients who exhibit suboptimal responses to adefovir-based combination rescue therapy due to resistance to nucleoside analogues (SATIS study)

BACKGROUND/AIMS: It remains to be determined whether switching from adefovir (ADV) to tenofovir (TDF) provides better virological outcomes in patients exhibiting suboptimal responses to ADV plus nucleoside analogue (ADV+NA) therapy for NA-resistant chronic hepatitis B (CHB). METHODS: In this prospec...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Mol Hepatol
Auteurs principaux: Lee, Hye Won, Park, Jun Yong, Kim, Beom Kyung, Kim, Moon Young, Lee, Jung Il, Kim, Young Suk, Yoon, Ki Tae, Han, Kwang-Hyub, Ahn, Sang Hoon
Format: Artigo
Langue:Inglês
Publié: The Korean Association for the Study of the Liver 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266340/
https://ncbi.nlm.nih.gov/pubmed/27880997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2016.0037
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires